News
TLC Sessions Podcast interviews the Research-Aid Networks team
On April 14, the Research-Aid Networks team published a hypothesis paper in Frontiers in Immunology that could potentially explain many of Long Covid’s widely varying symptoms. In early
Long Covid Expert Interview with Gez Medinger: Episode 33 – The Acid-Base Disruption Hypothesis for Long Covid
In early May, the Research-Aid Networks research team was interviewed by Gez Medinger, co-author of the Long Covid handbook and known from his Long Covid
New hypothesis on Long Covid published by Research-Aid Networks
The Research-Aid Networks team has published a hypothesis that could potentially explain many of Long Covid’s widely varying symptoms. The research article describing this hypothesis
This is The Long Haul, a look at some of the Long Covid stories we have heard
In the last two years, The Long Haul, an online series on Long Covid, has looked into what Long Covid is and what it means for
The Long Haul interviews Long Covid SOS co-founder
The long term consequences of COVID-19 known as Long Covid or post-acute sequelae of COVID-19 (PASC) has, since 2020, affected millions of lives around the
Here’s how a human bird flu pandemic could unfold
The largest ever global outbreak of avian influenza has started to jump to other animals. Are humans next? This article is written by Dr Jeremy
How soon after having COVID can you catch it again?
Yes, it’s possible to catch COVID after just having it. We are seeing more people getting COVID-19 a second, third or fourth time. Often it
Can you pass on COVID-19 if you’re testing negative?
In a word – yes. Yes, it is possible to still spread COVID-19 if you test negative but have cold-like symptoms. This is true if
Should we be worried that polio has been detected in the UK?
A national incident has been declared after the virus was found in a London sewer. The past weeks have seen continued transmission of SARS-CoV-2, new
Reality Check: How worried should we be about monkeypox?
It is unlikely the disease will become a new pandemic but cases are likely to rise over the coming weeks, virologist says. Though still in
COVID-19: Will we have to live with it forever? A virologist explains
A pandemic is a new outbreak of an infectious disease that affects a significant number of people in most countries around the world. There are
Rapid Response to nationwide cohort study: Long covid outcomes at one year after mild SARS-CoV-2 infection
On January 18, 2023, Research-Aid Networks and others sent a rapid response to BMJ regarding the study ‘Long covid outcomes at one year after mild
Concerns about study that minimizes the risks of Long COVID in children.
We recently published a collaborative commentary in Lancet Child & Adolescent Health raising methodological concerns about a recent study that minimizes the risks of Long COVID in children.
A vicious cycle in a pandemic – False words breed false promises, which breed false hope
Big changes, small differences, one constant – the ABCs of COVID A lot has changed since the world encountered the novel virus commonly known as
How worried should we be about the Omicron variant?
As research begins to emerge on the latest variant of COVID, should we be concerned about it and what makes it different to previous variants?
A Variant Holiday (safety in the time of Omicron)
With the simultaneous arrival of both the holidays and the Omicron variant, many of us are left wondering what this means for the holiday season
Promotion of non-evidence based therapeutics in Long COVID support groups
We recently published a collaborative article in Nature Medicine discussing the promotion of non-evidence based therapeutics in Long COVID support groups.
Long Covid Research Library
Update: The Long Covid Research Library was discontinued per June 2024 Research-Aid Networks has been working on a Long Covid research library since March 2021.
Healing Patient Europe conference at Vatican City
We assisted our partners from Europe, a Patient with the organising of a conference in collaboration with the Pontifical Academy of Social Sciences and the
COVID booster shots: How do they work and when will we need them?
Clinical trials are still investigating the effectiveness of COVID-19 booster jabs, while the UK Government have said millions may be offered a third jab from
Launch of online interview series on Long COVID
In collaboration with Pandemic-Aid Networks, we launched in 2021 an online interview series focusing on Long COVID. Named after the difficult journey those suffering from this unknown
The Impact of COVID Vaccination on Symptoms of Long COVID
Research-Aid Networks, in collaboration with the advocacy group LongCovidSOS, the University of Exeter and the University of Kent launched a survey to find out how
COVID-19 Guidance for individuals and organizations (June 2021)
Guide to the COVID-19 Pandemic Key Points Check your local COVID dashboard and know your local situation. If you’re in an area where
What we know about the UK COVID-19 variant
We have all heard about the new COVID-19 variant (B.1.1.7) that is spreading rapidly in the South of England and has been found in Denmark, the
COVID-19 vaccine messaging: we need to get it right the first time
Much of the world’s hope in controlling the COVID-19 pandemic rests on the creation and distribution of a safe and effective vaccine. While there has
Pandemic-Aid Networks
Pandemic-Aid Networks is an umbrella platform for COVID-19 advocacy groups, Long Covid groups and other COVID-focused groups and organizations across the globe. The network is
Pandemic-Aid Networks
Pandemic-Aid Networks is an umbrella platform for COVID-19 advocacy groups, Long Covid groups and other COVID-focused groups and organizations across the globe. The network is
Can we please stop talking about a second wave of COVID-19
Lockdown is easing. People are returning to work and shops are lifting their shutters. But we don’t have a vaccine and we’re a long way from achieving herd
Herd immunity in Europe – are we close?
While no country claims to be pursuing herd immunity as a strategy, some – such as Sweden – have taken a more relaxed approach to containing the
Coronavirus: is the R number still useful?
A few months ago, most people had never heard of the R number. Now, thanks to the novel coronavirus, we all know – or think
Coronavirus: four issues that have limited testing in the UK
Matt Hancock, the UK health secretary, promised 100,000 coronavirus tests a day by the end of April. On the last day of the month, the
Coronavirus linked to rare inflammatory disease in children – here’s what we know
The UK Paediatric Intensive Care Society sent out an alert on April 27 about an increase in cases of severe COVID-19-related illness in children. Since then, 19 cases have been
Coronavirus: many patients reporting neurological symptoms
As case numbers of COVID-19 continue to rise around the world, we are starting to see an increasing number of reports of neurological symptoms. Some
Coronavirus: the puzzle of why the risk of death is greater for men and for the elderly
For COVID-19, age and sex appear to be strong predictors of who lives and who dies. The fatality rate for the disease is estimated to be 0.66%,
Can I get the coronavirus twice?
There have been some cases, but is it too early to tell what is actually happening here? There have been a few stories in the
Coronavirus: will the UK really have highest death toll in Europe, as a US study suggests?
Within four months, the UK will have 66,314 fatalities from COVID-19, according to a recent report from the University of Washingon’s Institute for Health Metrics and Evaluation
Coronavirus: Why is Germany’s fatality rate so low?
Germany has received a great deal of attention for having a lower death rate for COVID-19 than most comparable European countries. A simple explanation for the
Coronavirus: what the 2009 swine flu pandemic can tell us about the weeks to come
The first documented case of COVID-19 is thought to have appeared on December 1 2019 in Wuhan, China. Four months later, the world is in the
Why are there so few coronavirus cases in Russia and Africa?
Since the COVID-19 pandemic began in Wuhan, China in December 2019, we have seen the virus spread to over 160 countries. Several countries have experienced large outbreaks,
A Clear Call for Government Action
The editors of Nature have recently published an excellent and clear discussion of the three things governments around the world need to do in order to combat
Coronavirus: Can herd immunity really protect us?
The UK government recently enacted its second phase of response to the COVID-19 pandemic: “delay”. According to ITV journalist Robert Peston, the government’s strategy to minimise
Will warmer weather stop the spread of coronavirus?
As the coronavirus death toll continues to rise, some have suggested that the approaching warmer spring weather in the northern hemisphere may slow or even stop
Novel Coronavirus (Covid19) Update
On the 1st of February, RAN reported on the outbreak of Coronavirus originating in Wuhan, Hubei province, China, and its implications for the region and the
Novel Coronavirus (nCoV) in China – Implications for Health and Communities
On the 8th of December 2019, Chinese authorities reported an instance of pneumonia of unknown origin. The World Health Organisation (WHO) confirmed the presence of a
Ebola in the DRC – October 2019 Update
Case figures as of 15th of October 2019: Confirmed: 3113, Probable: 114 Suspected: 411, Fatalities: 2152 If the recent figures are an accurate assessment of the Ebola virus
Ebola Virus in the Democratic Republic of the Congo
The current Ebola virus disease (EVD) outbreak in Eastern Democratic Republic of the Congo (DRC) will soon enter its second year. Beginning on 28 July
New Developments in the DRC Ebola Virus Outbreak
As the current Ebola virus outbreak in the DRC approaches the one year mark, two new developments may dramatically shape the outbreak and response in
Emerging Ebolavirus Therapies
The ongoing Ebolavirus disease (EVD) outbreak in North Kivu province, Democratic Republic of the Congo (DRC), is the first to use experimental vaccinations and drug
Continuing challenges in delivering effective aid
It has been just over one year since the first reported case of Ebola in North Kivu province of the DRC, and the outbreak is
Over 3,000 killed by deadly virus in Democratic Republic of the Congo this year – and it’s not Ebola
Ebola outbreaks, such as the current one in the Democratic Republic of the Congo (DRC), which has claimed 2,074 people’s lives, are widely covered in the media.